Cardiome Pharma Corp Information

View Top Employees from Cardiome Pharma Corp

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Patient Centered Research. We strive to find innovative medicines that provide value to patients, physicians and healthcare systems. We have two marketed products approved in Europe and other territories BrinavessTM (vernakalant IV), for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults and Aggrastat® a reversible GP IIb/IIIa inhibitor for use in Acute Coronary Syndrome patients. Investor Information Cardiome is traded on the NASDAQ Capital Market (CRME) and the Toronto Stock Exchange (COM).

Website	https://www.cardiome.com
Ticker	FRA:72R
Revenue	$25.3 million
Employees	43 (3 on RocketReach)
Founded	1986
Address	1441 Creekside Dr. 6th Fl, Vancouver, British Columbia V6J 4S7, CA
Phone	+1 604-677-6905
Fax	(604) 677-6915
Technologies	Microsoft Outlook , Microsoft Exchange Online , GoDaddy DNS +9 more (view full list)
Industry	Biotechnology, Healthcare, Biopharma, Cardiology Drug Discovery and Development, Pharmaceuticals, Drug Manufacturing & Research, Health Care, Science and Engineering
Web Rank	27 Million
Keywords	Cardiology, Cardiac, Cardiovascular Disease, Heart Rhythm, Heart Failure Treatment, Drug Discovery, Clinical Development, Drug Development, Treatment Development, Clinical Trials, Medical Research, Pharmaceutical Research, Therapeutic Innovation, Novel Therapies, Health Technology, Biopharmaceutical
Competitors	Amgen, Bristol Myers Squibb, Gilead Sciences, Lilly India, Pfizer, Johnson & Johnson, AstraZeneca, Roche, Novartis, Sanofi +44 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 5417 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies